Quidel (QDEL) Hits New 12-Month High and Low at $66.39

Quidel Co. (NASDAQ:QDEL)’s share price reached a new 52-week high and low during mid-day trading on Tuesday . The stock traded as low as $66.39 and last traded at $66.07, with a volume of 16094 shares traded. The stock had previously closed at $64.73.

Several research firms have recently issued reports on QDEL. Barclays restated a “buy” rating and set a $65.00 target price on shares of Quidel in a research report on Thursday, May 10th. TheStreet upgraded Quidel from a “c” rating to a “b” rating in a research report on Tuesday, May 8th. Zacks Investment Research upgraded Quidel from a “hold” rating to a “buy” rating and set a $62.00 target price for the company in a research report on Wednesday, April 25th. ValuEngine lowered Quidel from a “hold” rating to a “sell” rating in a research report on Wednesday, March 28th. Finally, BidaskClub upgraded Quidel from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, March 27th. One research analyst has rated the stock with a hold rating, six have assigned a buy rating and four have assigned a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $59.29.

The company has a quick ratio of 1.06, a current ratio of 1.36 and a debt-to-equity ratio of 0.40. The stock has a market cap of $2.42 billion, a PE ratio of -935.86, a P/E/G ratio of 1.12 and a beta of 0.91.

Quidel (NASDAQ:QDEL) last issued its quarterly earnings data on Tuesday, May 8th. The company reported $1.29 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.01 by $0.28. Quidel had a return on equity of 12.54% and a net margin of 3.08%. The business had revenue of $169.10 million during the quarter, compared to analyst estimates of $151.50 million. During the same period in the previous year, the firm earned $0.45 EPS. Quidel’s quarterly revenue was up 129.4% compared to the same quarter last year. equities research analysts expect that Quidel Co. will post 2.3 EPS for the current year.

In other Quidel news, CEO Douglas C. Bryant sold 12,000 shares of the company’s stock in a transaction that occurred on Tuesday, March 27th. The stock was sold at an average price of $51.51, for a total transaction of $618,120.00. Following the completion of the transaction, the chief executive officer now owns 306,313 shares of the company’s stock, valued at approximately $15,778,182.63. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Douglas C. Bryant sold 36,000 shares of the company’s stock in a transaction that occurred on Monday, April 30th. The stock was sold at an average price of $56.09, for a total value of $2,019,240.00. Following the transaction, the chief executive officer now directly owns 306,313 shares of the company’s stock, valued at approximately $17,181,096.17. The disclosure for this sale can be found here. Insiders sold a total of 201,006 shares of company stock valued at $11,728,499 over the last quarter. 16.70% of the stock is owned by insiders.

A number of large investors have recently added to or reduced their stakes in the business. California Public Employees Retirement System boosted its position in Quidel by 2.9% during the 4th quarter. California Public Employees Retirement System now owns 59,799 shares of the company’s stock worth $2,592,000 after acquiring an additional 1,696 shares during the last quarter. Chicago Equity Partners LLC boosted its position in Quidel by 4.8% during the 1st quarter. Chicago Equity Partners LLC now owns 47,060 shares of the company’s stock worth $2,438,000 after acquiring an additional 2,170 shares during the last quarter. Gagnon Securities LLC boosted its position in Quidel by 8.5% during the 1st quarter. Gagnon Securities LLC now owns 30,040 shares of the company’s stock worth $1,556,000 after acquiring an additional 2,353 shares during the last quarter. Swiss National Bank boosted its position in Quidel by 5.1% during the 1st quarter. Swiss National Bank now owns 49,600 shares of the company’s stock worth $2,570,000 after acquiring an additional 2,400 shares during the last quarter. Finally, Loomis Sayles & Co. L P boosted its position in Quidel by 1.0% during the 1st quarter. Loomis Sayles & Co. L P now owns 263,801 shares of the company’s stock worth $13,668,000 after acquiring an additional 2,519 shares during the last quarter. 90.15% of the stock is owned by hedge funds and other institutional investors.

About Quidel

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology. The company offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus products point-of-care products for the detection of infectious and inflammatory diseases and conditions of the eye.

Receive News & Ratings for Quidel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quidel and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply